HELLUMS RHONDA LYNETTE (CHIEF FINANCIAL OFFICER) received a stock award from ARATANA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/5/2019ACC: 0001209191-19-007450
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2019
+92.45K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
92.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+24.92K
Price / share
—
Trade value
—
% of position
94.0%
2/1/2019
26.50K→51.42K
Total
Net shares
+24.92K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2019 | A · Award | +24.92K | — | — | 94.0% | 26.50K | 51.42K |
| Total | +24.92K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
67.53K shares
Shares
+67.53K
Strike price
4.44
Held after
67.53K
Exercisable
—
2/1/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock67.53K shares | 2/1/2019 | A · Award | +67.53K | 4.44 | — | 67.53K |